Tag results:

PI3K

Targeting the NOTCH1-MYC-CD44 Axis in Leukemia-Initiating Cells in T-ALL

[Leukemia] Secondary transplantation from PDX and ΔPTEN models of T-cell acute lymphoblastic leukemia (T-ALL), confirmed delayed leukemia development and extended survival of mice engrafted with T-ALL from ARV-825 treated mice, providing functional confirmation of depletion of leukemia-initiating cells.

The PI3K/Akt/mTOR Pathway in Lung Cancer; Oncogenic Alterations, Therapeutic Opportunities, Challenges, and a Glance at the Application of Nanoparticles

[Translational Oncology] The authors summarize the original data obtained from international research laboratories on the oncogenic alterations in each component of the PI3K/Akt/mTOR pathway in lung cancer.

Personalized Chordoma Organoids for Drug Discovery Studies

[Science Advances] In this proof-of-concept study, the authors successfully established organoids from seven chordoma tumor samples obtained from five patients presenting with tumors in different sites and stages of disease.

CircKDM4B Suppresses Breast Cancer Progression via the miR-675/NEDD4L Axis

[Oncogene] CircKDM4B inhibited migration and tube formation of HUVECs in vitro and angiogenesis in vivo.

Tumor Microenvironment Acidity Triggers Lipid Accumulation in Liver Cancer via SCD1 Activation

[Molecular Cancer Research] Investigators revealed that acidosis could significantly trigger fatty acid synthesis to promote liver tumorigenesis by upregulating SCD1 in a PI3K/AKT activation dependent manner and simultaneously promote SCD1 binding to PPARα.

CTCFL Regulates the PI3K-Akt Pathway and It Is a Target for Personalized Ovarian Cancer Therapy

[npj Systems Biology and Applications] The authors used in vitro models to evaluate the transcriptional changes due to the presence of CTCFL, followed by a selection of gene candidates using de novo network enrichment analysis.

Popular